Abstract: System and methods configured to permit a user such as a health care provider to organize and manage patient information quickly and efficiently from a simplified representation. Such simplified representations may include a patient representation and a context representation. The representations may be updated to represent real-time patient conditions through the input of information directly from treatment or monitoring devices or from user input.

Abstract: A method and system are disclosed for evaluating symptomatic vertebrobasilar disease VBD which uses quantitative hemodynamic assessment in order to identify patients at high risk for stroke and provide appropriate guidance for intervention. Patients with symptomatic VBD may be considered for intervention to provide blood flow augmentation if evidence of sufficient flow compromise is present as defined by specific flow criteria, and treated medically otherwise.

Abstract: A method and system are disclosed for evaluating symptomatic VBD which uses quantitative hemodynamic assessment in order to identify patients at high risk for stroke and provide appropriate guidance for intervention. Patients with symptomatic VBD may be considered for intervention to provide blood flow augmentation if evidence of sufficient flow compromise is present as defined by specific flow criteria, and treated medically otherwise.

Abstract: A method and system for evaluating the cerebral circulation of a patient is described. The arterial network of the brain is partitioned into a plurality of different regions where each region is supplied with blood by particular cerebral arteries. Volume flows into the regions are calculated from the measured volume flows of the cerebral arteries using quantitative magnetic resonance angiography. The cerebrovascular circulation of an individual patient may therefore be evaluated for the presence of disease by comparing the regional blood flows of the patient to normal values as obtained from population data.

Abstract: A method and system are disclosed for evaluating symptomatic VBD which uses quantitative hemodynamic assessment in order to identify patients at high risk for stroke and provide appropriate guidance for intervention. Patients with symptomatic VBD may be considered for intervention to provide blood flow augmentation if evidence of sufficient flow compromise is present as defined by specific flow criteria, and treated medically otherwise.

Abstract: A method and system are disclosed for evaluating symptomatic VBD which uses quantitative hemodynamic assessment in order to identify patients at high risk for stroke and provide appropriate guidance for intervention. Patients with symptomatic VBD may be considered for intervention to provide blood flow augmentation if evidence of sufficient flow compromise is present as defined by specific flow criteria, and treated medically otherwise.